Literature DB >> 11087046

Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology.

I Brigger1, P Chaminade, D Desmaële, M T Peracchia, J d'Angelo, R Gurny, M Renoir, P Couvreur.   

Abstract

PURPOSE: To progress in the characterization of a poly(MePEGcyanoacrylate-co-hexadecylcyanoacrylate) (poly(PEGCA-co-HDCA) copolymer and the nanoparticles formed from this copolymer.
METHODS: Poly(PEGCA-co-HDCA) at a MePEG/hexadecyl ratio of 1:4 was investigated by 1H-NMR and near infrared spectroscopy. The nanoparticle suspensions, obtained by the methods of nanoprecipitation or emulsion--solvent evaporation, as well as the crude nanoparticles and their dispersion medium--were analyzed by MePEG measurement, 1H-NMR, and near infrared spectroscopy.
RESULTS: The 1H-NMR results showed that the (poly(PEGCA-co-HDCA) copolymer obtained bore lateral hydrophilic MePEG chains and lateral hydrophobic hexadecyl chains in a final ratio of 1:4. However, this ratio, although reproducible from batch to batch, represented only a mean value for different molecular species. Indeed, our results demonstrated the formation of more hydrophobic poly(alkyl-cyanoacrylate) oligomers (with a higher content of hexadecyl chains) and other more hydrophilic oligomers (with a higher MePEG content). Only the more hydrophobic oligomers were able to form solid pegylated nanoparticles. As far as these nanoparticles were concerned, determination of their MePEG content allowed the calculation of a distance of 1.2 nm and 1.05 nm between 2 grafted MePEG chains at the nanoparticle surface, when obtained by nanoprecipitation and emulsion-solvent evaporation, respectively. Moreover, when the same copolymer batch was used, different nanoparticles were obtained according to the preparation method, as seen by near infrared spectroscopy.
CONCLUSIONS: The nanoparticles obtained by nanoprecipitation or emulsion-solvent evaporation of poly(PEGCA-co-HDCA) 1:4 copolymer displayed a different supramolecular organization, as evidenced by the near infrared spectroscopy results. Moreover, these nanoparticles showed surface characteristics compatible with a long circulating carrier.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087046     DOI: 10.1023/a:1026465931525

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Development and validation of a method for the analysis of a pharmaceutical preparation by near-infrared diffuse reflectance spectroscopy.

Authors:  M Blanco; J Coello; A Eustaquio; H Iturriaga; S Maspoch
Journal:  J Pharm Sci       Date:  1999-05       Impact factor: 3.534

2.  Controlling liposome blood clearance by surface-grafted polymers.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

3.  Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.

Authors:  M T Peracchia; C Vauthier; D Desmaële; A Gulik; J C Dedieu; M Demoy; J d'Angelo; P Couvreur
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators.

Authors:  M Vittaz; D Bazile; G Spenlehauer; T Verrecchia; M Veillard; F Puisieux; D Labarre
Journal:  Biomaterials       Date:  1996-08       Impact factor: 12.479

5.  Diffuse reflectance near-infrared spectroscopy as a nondestructive analytical technique for polymer implants.

Authors:  R L Brashear; D R Flanagan; P E Luner; J J Seyer; M S Kemper
Journal:  J Pharm Sci       Date:  1999-12       Impact factor: 3.534

6.  Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.

Authors:  M T Peracchia; S Harnisch; H Pinto-Alphandary; A Gulik; J C Dedieu; D Desmaële; J d'Angelo; R H Müller; P Couvreur
Journal:  Biomaterials       Date:  1999-07       Impact factor: 12.479

7.  Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.

Authors:  M T Peracchia; E Fattal; D Desmaële; M Besnard; J P Noël; J M Gomis; M Appel; J d'Angelo; P Couvreur
Journal:  J Control Release       Date:  1999-06-28       Impact factor: 9.776

8.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

Authors:  D Bazile; C Prud'homme; M T Bassoullet; M Marlard; G Spenlehauer; M Veillard
Journal:  J Pharm Sci       Date:  1995-04       Impact factor: 3.534

  8 in total
  5 in total

Review 1.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

2.  Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Authors:  P Calvo; B Gouritin; H Chacun; D Desmaële; J D'Angelo; J P Noel; D Georgin; E Fattal; J P Andreux; P Couvreur
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

3.  The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers.

Authors:  Irène Brigger; Laurence Armand-Lefevre; Pierre Chaminade; Madeleine Besnard; Yohan Rigaldie; Alain Largeteau; Antoine Andremont; Luc Grislain; Gérard Demazeau; Patrick Couvreur
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

4.  Application of albumin-based nanoparticles in the management of cancer.

Authors:  Xinzhe Yu; Chen Jin
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

5.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.

Authors:  E Garcia-Garcia; S Gil; K Andrieux; D Desmaële; V Nicolas; F Taran; D Georgin; J P Andreux; F Roux; P Couvreur
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.